title: The Kuvan(®) Adult Maternal Paediatric European Registry (KAMPER) Multinational Observational Study: Baseline and 1-Year Data in Phenylketonuria Patients Responsive to Sapropterin.
abstract: BACKGROUND
  Sapropterin dihydrochloride (Kuvan(®)), a synthetic 6R-diastereoisomer of tetrahydrobiopterin (BH4), is approved in Europe for the treatment of patients aged ≥4 years with hyperphenylalaninaemia (HPA) due to BH4-responsive phenylalanine hydroxylase (PAH) deficiency, in conjunction with a phenylalanine-restricted diet, and also for the treatment of patients with BH4 deficiency.
  
  
  OBJECTIVE
  KAMPER is an ongoing, observational, multicentre registry with the primary objective of providing information over 15 years on long-term safety of sapropterin dihydrochloride treatment in patients with HPA. Here we report initial data on characteristics from patients recruited by the time of the third interim analysis and results at 1 year.
  
  
  RESULTS
  Overall, 325 patients from 55 sites in seven European countries were included in the analysis: 296 (91.1%) patients with PAH deficiency (median [Q1, Q3] age, 10.3 [7.2, 15.0] years) and 29 (8.9%) with BH4 deficiency (12.8 [6.6, 18.9] years). Fifty-nine patients (18.2%) were aged ≥18 years; 4 patients were pregnant. No elderly patients (aged ≥65 years) or patients with renal or hepatic insufficiency were enroled in the study. Twelve-month data were available for 164 patients with PAH deficiency and 16 with BH4 deficiency. No new safety concerns were identified as of May 2013.
  
  
  CONCLUSIONS
  Initial data from KAMPER show that sapropterin dihydrochloride has a favourable safety profile. Registry data collected over time will provide insight into the management and outcomes of patients with PAH deficiency and BH4 deficiency, including long-term safety, impact on growth and neurocognitive outcomes and the effect of sapropterin dihydrochloride treatment on populations of special interest.
authors.affiliation: Department of Pediatrics, University of Heidelberg, Heidelberg, Germany, friedrich.trefz@gmx.de.
authors.forename: Friedrich K
authors.initials: FK
authors.lastname: Trefz
authors.forename: Ania C
authors.initials: AC
authors.lastname: Muntau
authors.forename: Florian B
authors.initials: FB
authors.lastname: Lagler
authors.forename: Flavie
authors.initials: F
authors.lastname: Moreau
authors.forename: Jan
authors.initials: J
authors.lastname: Alm
authors.forename: Alberto
authors.initials: A
authors.lastname: Burlina
authors.forename: Frank
authors.initials: F
authors.lastname: Rutsch
authors.forename: Amaya
authors.initials: A
authors.lastname: Bélanger-Quintana
authors.forename: François
authors.initials: F
authors.lastname: Feillet
references.citation: Pediatr Res. 2004 Mar;55(3):425-30
references.pmid: 14681498
references.citation: J Biol Chem. 1993 Jun 15;268(17):12231-4
references.pmid: 7685338
references.citation: J Pediatr. 2007 Jun;150(6):627-30
references.pmid: 17517248
references.citation: Pediatrics. 2013 Jun;131(6):e1881-8
references.pmid: 23690520
references.citation: J Inherit Metab Dis. 1996;19(1):8-14
references.pmid: 8830181
references.citation: J Inherit Metab Dis. 2014 Sep;37(5):753-62
references.pmid: 24789341
references.citation: J Inherit Metab Dis. 2007 Oct;30(5):700-7
references.pmid: 17846916
references.citation: J Biol Chem. 1972 Jul 10;247(13):4165-73
references.pmid: 4402511
references.citation: J Pediatr. 1999 Sep;135(3):375-8
references.pmid: 10484807
references.citation: Lancet. 2010 Oct 23;376(9750):1417-27
references.pmid: 20971365
references.citation: Mol Genet Metab. 2013 Mar;108(3):149-54
references.pmid: 23352389
references.citation: Mol Genet Metab. 2005 Dec;86 Suppl 1:S54-60
references.pmid: 16040265
references.citation: Mol Genet Metab. 2009 Apr;96(4):158-63
references.pmid: 19208488
references.citation: J Biol Chem. 1971 Mar 10;246(5):1330-40
references.pmid: 5545077
references.citation: Mol Genet Metab. 2014 May;112(1):9-16
references.pmid: 24667082
references.citation: Mol Genet Metab. 2012 Nov;107(3):294-301
references.pmid: 23062575
references.citation: Lancet. 2007 Aug 11;370(9586):504-10
references.pmid: 17693179
references.citation: J Pediatr. 2009 May;154(5):700-7
references.pmid: 19261295
references.citation: Curr Drug Metab. 2002 Apr;3(2):123-31
references.pmid: 12003346